コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 logy with Mn-superoxide dismutase of MAC and Mycobacterium leprae.
2 tro, monocytes produced IL-18 in response to Mycobacterium leprae.
3 associated with active cellular immunity to Mycobacterium leprae.
4 man pathogens Mycobacterium tuberculosis and Mycobacterium leprae.
5 atients, who have potent T cell responses to Mycobacterium leprae.
6 e-rich antigens found in M. tuberculosis and Mycobacterium leprae.
7 libraries of Mycobacterium tuberculosis and Mycobacterium leprae.
8 to be Mycobacterium lepromatosis instead of Mycobacterium leprae.
9 cells by an intracellular bacterial pathogen Mycobacterium leprae.
10 predicted for Mycobacterium tuberculosis and Mycobacterium leprae.
11 ux pump in all sequenced mycobacteria except Mycobacterium leprae.
12 eprosy, an intracellular infection caused by Mycobacterium leprae.
13 in Mexico, wild armadillos are infected with Mycobacterium leprae.
14 disease caused by the intracellular pathogen Mycobacterium leprae.
15 Leprosy is caused by infection with Mycobacterium leprae.
16 gy and immune responses that fail to control Mycobacterium leprae.
17 ses including infection with leprosy-causing Mycobacterium leprae.
18 proteins are conserved within the genome of Mycobacterium leprae.
19 h the type of immune response mounted toward Mycobacterium leprae.
20 cellular parasites Rickettsia prowazekii and Mycobacterium leprae.
21 aired mitogenesis in response to antigens of Mycobacterium leprae.
23 ising the N-terminal portion of the putative Mycobacterium leprae 19-kDa lipoprotein, triggered an in
26 egments revealed significant divergence from Mycobacterium leprae, a well-known cause of leprosy, tha
27 possible to distinguish different strains of Mycobacterium leprae according to their genetic sequence
29 /nu) mice were infected in the footpads with Mycobacterium leprae and fed a linoleic acid-free diet.
30 ns is largely determined by host immunity to Mycobacterium leprae and is a model for immunoregulation
32 Comparison of ancient and modern genomes of Mycobacterium leprae and Mycobacterium tuberculosis give
33 overall) and is 50% identical to FAP of both Mycobacterium leprae and Mycobacterium tuberculosis.
36 een shown to recognize specifically LAM from Mycobacterium leprae and not from M. tuberculosis Erdman
37 lar bacterial pathogens in humans, including Mycobacterium leprae and Salmonella enterica serovar Typ
38 lysis to identify genes that are specific to Mycobacterium leprae and tested both recombinant protein
39 gated the role of TLRs in the recognition of Mycobacterium leprae and the significance of TLR2Arg(677
41 tions in codon 53 or 55 of the folP1 gene of Mycobacterium leprae, and definitive evidence linking th
43 Several Mycobacterium tuberculosis strains, Mycobacterium leprae, and other mycobacterial pathogens
44 ll wall layer of Mycobacterium tuberculosis, Mycobacterium leprae, and several opportunistic mycobact
48 resistance surveillance and strain typing of Mycobacterium leprae are necessary to investigate ongoin
49 plied to the obligate intracellular organism Mycobacterium leprae because of the difficulty of obtain
50 or/interleukin-10 ratio when stimulated with Mycobacterium leprae but not with lipopolysaccharide or
51 ctional homology of the Nramp homologue from Mycobacterium leprae by using a yeast complementation as
54 rkers to induce cellular immune responses to Mycobacterium leprae: CD1a mediates the presentation of
55 lenge in animal models, for efficacy against Mycobacterium leprae challenge in a murine model of lepr
58 ng pathogen-associated molecular patterns of Mycobacterium leprae, cytokine release by innate immune
59 sis and then therapeutically vaccinated with Mycobacterium leprae-derived hsp65 DNA develop severe gr
61 xperimental leprosy, both low- and high-dose Mycobacterium leprae foot pad (FP) infections were evalu
62 ple sequence repeats, or microsatellites, in Mycobacterium leprae from patients living in and around
63 NA sequence analysis of cosmid L373 from the Mycobacterium leprae genome, an open reading frame of 1.
64 odel for the accretion of pseudogenes in the Mycobacterium leprae genome, triggered by the loss of di
65 n in animals and cultures, the cell walls of Mycobacterium leprae grown in armadillos was characteriz
66 A DNA vaccine encoding the hsp60 molecule of Mycobacterium leprae has previously been shown to protec
68 ifloxacin, and assessed the potential of the Mycobacterium leprae heat shock protein-65 DNA vaccine t
73 loped an in vitro model to study the fate of Mycobacterium leprae in a LL lesion, with and without im
74 gle nucleotide polymorphism (SNP) typing for Mycobacterium leprae in biopsied skin lesion samples.
75 unit of the phenolic glycolipid-1 (PGL-1) of Mycobacterium leprae in determining the bacterial predil
76 f IL-12Rbeta2 on T cells was up-regulated by Mycobacterium leprae in tuberculoid but not in lepromato
78 ctivate T cells that recognize the pathogen, Mycobacterium leprae, in a langerin-dependent manner.
79 , with the exception of the peptidoglycan of Mycobacterium leprae, in which glycine replaces the L-al
81 e degenerate genome of the leprosy bacillus, Mycobacterium leprae, indicating that non-essential func
84 Herein, a global gene expression profile of Mycobacterium leprae-infected primary human Schwann cell
90 the molecular basis of the neural tropism of Mycobacterium leprae is attributable to the specific bin
91 To understand how the immune response to Mycobacterium leprae is regulated, human dendritic cells
94 rosy, a chronic infectious disease caused by Mycobacterium leprae, is prevalent in India, where about
95 1990s, transmission of the causative agent, Mycobacterium leprae, is still occurring, and new cases
98 atis and like Mycobacterium tuberculosis and Mycobacterium leprae, M. marinum was shown to possess a
99 d two other crystal structures for RuvA from Mycobacterium leprae (MleRuvA) and EcoRuvA showed that i
100 smegmatis with the homologous sequences from Mycobacterium leprae, Mycobacterium bovis, and Mycobacte
101 of leprosy, attributed to early invasion by Mycobacterium leprae of Schwann cells related to unmyeli
102 wing exposure to Mycobacterium tuberculosis, Mycobacterium leprae or Mycobacterium avium is correlate
104 cognize lipid Ags from the leprosy pathogen, Mycobacterium leprae, or the related species, Mycobacter
105 terium tuberculosis, Mycobacterium bovis, or Mycobacterium leprae; or in the non-mycobacterial Actino
106 Accordingly, comparative bioinformatics and Mycobacterium leprae protein microarrays were applied to
107 d demyelination and axonal injury induced by Mycobacterium leprae provides a model for elucidating th
108 n to both CD1b- and MHC class II-restricted, Mycobacterium leprae-reactive T cells derived from lepro
110 riation by neutron scattering was applied to Mycobacterium leprae RuvA (MleRuvA), a synthetic analogu
112 ilarity to the enzyme from cyanobacteria and Mycobacterium leprae, similarity to the conserved transa
113 d lateral flow assays (LFA) for detection of Mycobacterium leprae-specific antibodies: the visual imm
117 treatment with five different microbial hsp (Mycobacterium leprae, Streptococcus pneumoniae, Helicoba
118 reased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechan
119 conserved in Mycobacterium tuberculosis and Mycobacterium leprae, suggesting that regulation of DNA
121 to investigate the molecular epidemiology of Mycobacterium leprae, the causative agent of leprosy, du
123 tect leprosy and to stop the transmission of Mycobacterium leprae, the causative bacillus of the dise
125 wann cell response to long-term infection of Mycobacterium leprae, the causative organism of leprosy,
127 hown to serve as a Schwann cell receptor for Mycobacterium leprae, the causative organism of leprosy.
130 ing treatment of monocytes with IFN-beta and Mycobacterium leprae, the intracellular bacterium that c
132 tools for the differentiation of isolates of Mycobacterium leprae, the organism that causes leprosy,
133 ng characteristics of the causative bacillus Mycobacterium leprae: the long incubation period, limite
134 xide stress response in enteric bacteria) in Mycobacterium leprae, this gene is inactive in all strai
135 six new proteins isolated from in vivo-grown Mycobacterium leprae, three of which correspond to produ
136 idermal LCs presented nonpeptide antigens of Mycobacterium leprae to T cell clones derived from a lep
137 the species-specific phenolic glycolipid of Mycobacterium leprae triggers uptake into Schwann cells
139 idoglycan from in vivo-derived noncultivable Mycobacterium leprae was assumed to possess the basic st
140 otide sequence of 1.5 Mb of genomic DNA from Mycobacterium leprae was determined using computer-assis
141 PBMC of tuberculoid patients stimulated with Mycobacterium leprae was partially inhibited by mAbs to
142 ganization of TrxR and Trx has been found in Mycobacterium leprae, where TrxR and Trx are encoded by
144 f human leprosy, yet it is not clear whether Mycobacterium leprae, which has a distinct MDP structure
145 exican patient, and compared it with that of Mycobacterium leprae, which has undergone extensive redu
146 sy is a chronic infectious disease caused by Mycobacterium leprae, which primarily infects macrophage
147 me sequences of certain pathogenic bacteria (Mycobacterium leprae, Yersinia pestis and Rickettsia pro
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。